Skip to main content

Guaifenesin / phenylephrine / pyrilamine Pregnancy and Breastfeeding Warnings

Brand names: A-Tan 12X, Ryna-12X

Guaifenesin / phenylephrine / pyrilamine Pregnancy Warnings

Guaifenesin/phenylephrine/pyrilamine has been assigned to a pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Guaifenesin/phenylephrine/pyrilamine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Guaifenesin / phenylephrine / pyrilamine Breastfeeding Warnings

There are no data on the excretion of guaifenesin/phenylephrine/pyrilamine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. Product Information. Ryna-12X (guaifenesin/phenylephrine/pyrilamine). Meda AB. 2003.

References for breastfeeding information

  1. Product Information. Ryna-12X (guaifenesin/phenylephrine/pyrilamine). Meda AB. 2003.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.